J Pediatr Genet 2021; 10(01): 081-084
DOI: 10.1055/s-0040-1710330
Case Report

A Novel Frameshift Mutation in KAT6A Is Associated with Pancraniosynostosis

1   Department of Plastic Surgery and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Jennifer A. Hall
1   Department of Plastic Surgery and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Erin Anstadt
1   Department of Plastic Surgery and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Suneeta Madan-Khetarpal
2   Department of Genetics, Center for Clinical Genetics and Genomics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Jesse A. Goldstein
1   Department of Plastic Surgery and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Joseph E. Losee
1   Department of Plastic Surgery and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
› Author Affiliations
Funding None.

Abstract

De novo heterozygous mutations in the KAT6A gene give rise to a distinct intellectual disability syndrome, with features including speech delay, cardiac anomalies, craniofacial dysmorphisms, and craniosynostosis. Here, we reported a 16-year-old girl with a novel pathogenic variant of the KAT6A gene. She is the first case to possess pancraniosynostosis, a rare suture fusion pattern, affecting all her major cranial sutures. The diagnosis of KAT6A syndrome is established via recognition of its inherent phenotypic features and the utilization of whole exome sequencing. Thorough craniofacial evaluation is imperative, craniosynostosis may require operative intervention, the delay of which may be detrimental.

Ethical Statement

This article does not contain any studies with human or animal subjects performed by any of the authors.




Publication History

Received: 31 January 2020

Accepted: 23 March 2020

Article published online:
25 April 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Champagne N, Pelletier N, Yang XJ. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 2001; 20 (03) 404-409
  • 2 Millan F, Cho MT, Retterer K. et al. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder. Am J Med Genet A 2016; 170 (07) 1791-1798
  • 3 Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C. MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc Natl Acad Sci U S A 2013; 110 (10) 3895-3900
  • 4 Perez-Campo FM, Costa G, Lie-A-Ling M, Stifani S, Kouskoff V, Lacaud G. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells. Stem Cells 2014; 32 (06) 1591-1601
  • 5 Leung KS, Cheng VW, Mok SW, Tsui SK. The involvement of DNA methylation and histone modification on the epigenetic regulation of embryonic stem cells and induced pluripotent stem cells. Curr Stem Cell Res Ther 2014; 9 (05) 388-395
  • 6 Kim W, Choi M, Kim JE. The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle. Cell Cycle 2014; 13 (05) 726-738
  • 7 Hibiya K, Katsumoto T, Kondo T, Kitabayashi I, Kudo A. Brpf1, a subunit of the MOZ histone acetyl transferase complex, maintains expression of anterior and posterior Hox genes for proper patterning of craniofacial and caudal skeletons. Dev Biol 2009; 329 (02) 176-190
  • 8 Voss AK, Collin C, Dixon MP, Thomas T. Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. Dev Cell 2009; 17 (05) 674-686
  • 9 Kennedy J, Goudie D, Blair E. et al; DDD Study. KAT6A syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants. Genet Med 2019; 21 (04) 850-860
  • 10 Tham E, Lindstrand A, Santani A. et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. Am J Hum Genet 2015; 96 (03) 507-513
  • 11 Blount JP, Louis Jr RG, Tubbs RS, Grant JH. Pansynostosis: a review. Childs Nerv Syst 2007; 23 (10) 1103-1109
  • 12 Gauthier-Vasserot A, Thauvin-Robinet C, Bruel AL. et al. Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability. Am J Med Genet A 2017; 173 (01) 62-71
  • 13 Arboleda VA, Lee H, Dorrani N. et al; UCLA Clinical Genomics Center. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet 2015; 96 (03) 498-506
  • 14 Satoh C, Maekawa R, Kinoshita A. et al. Three brothers with a nonsense mutation in KAT6A caused by parental germline mosaicism. Hum Genome Var 2017; 4: 17045
  • 15 Elenius V, Lähdesmäki T, Hietala M, Jartti T. Food allergy in a child with de novo KAT6A mutation. Clin Transl Allergy 2017; 7: 19
  • 16 Murray CR, Abel SN, McClure MB. et al. Novel causative variants in DYRK1A, KARS, and KAT6A associated with intellectual disability and additional phenotypic features. J Pediatr Genet 2017; 6 (02) 77-83
  • 17 Zwaveling-Soonawala N, Maas SM, Alders M. et al. Variants in KAT6A and pituitary anomalies. Am J Med Genet A 2017; 173 (09) 2562-2565
  • 18 Vissers LE, de Ligt J, Gilissen C. et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42 (12) 1109-1112
  • 19 de Ligt J, Willemsen MH, van Bon BW. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367 (20) 1921-1929
  • 20 Yang Y, Muzny DM, Reid JG. et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369 (16) 1502-1511
  • 21 Di Rocco F, Arnaud E, Renier D. Evolution in the frequency of nonsyndromic craniosynostosis. J Neurosurg Pediatr 2009; 4 (01) 21-25
  • 22 Slater BJ, Lenton KA, Kwan MD, Gupta DM, Wan DC, Longaker MT. Cranial sutures: a brief review. Plast Reconstr Surg 2008; 121 (04) 170e-178e
  • 23 Governale LS. Craniosynostosis. Pediatr Neurol 2015; 53 (05) 394-401
  • 24 Lenton KA, Nacamuli RP, Wan DC, Helms JA, Longaker MT. Cranial suture biology. Curr Top Dev Biol 2005; 66: 287-328
  • 25 Posnick JC. Craniofacial Syndromes and Anomalies in Children and Young Adults. vol. 1. Philadelphia: Saunders; 2000
  • 26 Cohen Jr MM. Craniosynostosis and syndromes with craniosynostosis: incidence, genetics, penetrance, variability, and new syndrome updating. Birth Defects Orig Artic Ser 1979; 15 (5B): 13-63
  • 27 Marchac D, Renier D. Craniosynostosis. World J Surg 1989; 13 (04) 358-365
  • 28 Panchal J, Uttchin V. Management of craniosynostosis. Plast Reconstr Surg 2003; 111 (06) 2032-2048 , quiz 2049
  • 29 Eide PK, Helseth E, Due-Tønnessen B, Lundar T. Changes in intracranial pressure after calvarial expansion surgery in children with slit ventricle syndrome. Pediatr Neurosurg 2001; 35 (04) 195-204
  • 30 Foo R, Whitaker LA, Bartlett SP. Normocephalic pancraniosynostosis resulting in late presentation of elevated intracranial pressures. Plast Reconstr Surg 2010; 125 (05) 1493-1502
  • 31 Scott JR, Isom CN, Gruss JS. et al. Symptom outcomes following cranial vault expansion for craniosynostosis in children older than 2 years. Plast Reconstr Surg 2009; 123 (01) 289-297 , discussion 298–299